Skeletal effects of calcitonin in ovariectomized rats.
Although calcitonin (CT) has been shown to be effective for the prevention of bone loss in early postmenopausal women, the skeletal effects of the hormone specifically during the early stages of estrogen deficiency have not been characterized histomorphometrically to date. The current study involves use of the ovariectomized (OVX) rat as an animal model for early postmenopausal bone loss to perform such a histomorphometric analysis. One group of OVX rats was injected sc with salmon CT on alternate days for a 6-week period. Additional groups of OVX and sham-operated control rats were treated with vehicle alone. In comparison to control rats, the proximal tibia of vehicle-treated OVX rats were characterized by a 3-fold decrease in cancellous bone volume and significant increases in osteoblast surface (+200%), osteoclast surface (+143%), mineralizing surface (+111%), mineral apposition rate (+36%), bone formation rate (+181%), and longitudinal bone growth (+38%). In contrast, treatment of OVX rats with CT normalized tibial cancellous bone volume and significantly decreased all of the above cellular- and fluorochrome-based indices of bone turnover to near control levels. The results indicate that CT treatment depresses bone turnover and prevents the development of osteopenia in OVX rats. These findings are consistent with the bone protective effect of CT in early postmenopausal women and further support the OVX rat as an animal model for the preclinical evaluation of prophylactic treatments for postmenopausal bone loss.
Wronski
T J
TJ
Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville 32610.
Yen
C F
CF
Burton
K W
KW
Mehta
R C
RC
Newman
P S
PS
Soltis
E E
EE
DeLuca
P P
PP
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001846:Bone Development / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects*; D002116:Calcitonin / Q000494:pharmacology*; D002118:Calcium / Q000097:blood; D005260:Female; D010052:Ovariectomy; D014677:Pharmaceutical Vehicles; D051381:Rats; D011919:Rats, Inbred Strains; D013977:Tibia / Q000187:drug effects
D014677:Pharmaceutical Vehicles; D002116:Calcitonin; D002118:Calcium